Discover
Visualize rapid, validated insights through real-world data.
RWE upstart maps a new global plan as investors pour in the latest mega-round
As regulators continue to rely more on real world evidence, New York-based RWE leader ...
ICER pilot project to use real-world evidence in hereditary angioedema treatments value assessment update
Evidence Base Online reports The Institute for Clinical and Economic Review (ICER; MA, ...
ICER to incorporate RWE into assessment of HAE drugs
The US Institute for Clinical and Economic Review (ICER) has announced that it is using ...
ICER launches pilot program to update past assessments using real-world data
Jazz Pharmaceuticals has received priority review from the FDA for expanding the use of ...
Accelerated approval, real-world evidence pilot from ICER, Aetion picks HAE as first therapeutic area
ICER signals how it will pick other therapies for pilot in an interview with Pink Sheet. ...
Coronavirus infection leads to immunity that’s comparable to a COVID-19 vaccine
One of the enduring questions of the COVID-19 pandemic is how much immunity people are ...
COVID-19 antibodies may protect against reinfection later, study suggests
A study published in the journal JAMA Internal Medicine found that people who tested ...
Aetion: Fierce 15 Awards 2021
Amidst unprecedented challenges, adaptability emerged as a key determinant of success for ...
SARS-CoV-2 antibodies can protect from reinfection, NCI study suggests
As COVID-19 vaccines start to roll out in the US, research led by the National Cancer ...
Her Story podcast: Fitting the pieces together with Carolyn Magill
This podcast episode features an interview with Carolyn Magill, the CEO of Aetion, a ...
‘Unpredictable pathogen’: New coronavirus study highlights severity of illness
While COVID-19 is commonly associated with symptoms like a loss of smell or taste, a new ...
Health analytics startup expands partnership with global pharma firm
As president and chief operating officer of Mount Sinai Hospital, Dr. David Reich ...
Data-driven approach to COVID-19 requires rigor, transparency
Aetion CEO Carolyn Magill spoke with S&P Global Market Intelligence about the ...
MedCity Pivot: Real-world evidence with Carolyn Magill
Arundhati Parmar interviewed Carolyn Magill, CEO of Aetion. They discussed the growing ...
Ask the Experts: applications of real-world data during—and beyond—COVID-19
In this ‘Ask the Experts’ feature, explore some of the potential applications of ...
Aetion adds another $19M to its Series B to make sense of drug development and treatment data
AlleyWatch caught up with CEO Carolyn Magill to learn more about how the company powers ...
Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight
Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new ...
Aetion, Cegedim Health Data partner on European RWE effort
Outsourcing Pharma writes in July 2020, Aetion and Cegedim Health Data announce plans to ...
Aetion, Cegedim form transatlantic real-world data alliance
Health tech companies Aetion and Cegedim have agreed to combine their data platforms, to ...
The Cures Act’s second act: Six ways to ensure Congress doubles down on its boldest bet
When the 21st Century Cures Act became law in 2016, the legislation boldly funded the ...
Real-world data partnership on COVID-19: US FDA drawn to consistency, diversity of Aetion's datasets
FDA's Amy Abernethy tells the Pink Sheet that initial priorities are likely to include ...
FDA partners with Aetion to gather real-world data on the coronavirus
The Food and Drug Administration has invested in real-world data for several years, ...
FDA, Aetion partner on real-world data analytics for COVID-19
EndpointsNews writes in 2020 that the FDA will partner with New York-based health ...
FDA, Aetion team up on real-world evidence research in COVID-19
Aetion has partnered with the Food and Drug Administration (FDA) to utilize real-world ...